Related references
Note: Only part of the references are listed.Potential drug-drug interactions and their risk factors in pediatric patients admitted to the emergency department of a tertiary care hospital in Mexico
Olga Morales-Rios et al.
PLOS ONE (2018)
Frequency, characteristics and risk factors of QT interval prolonging drugs and drug-drug interactions in cancer patients: a multicenter study
Qasim Khan et al.
BMC PHARMACOLOGY & TOXICOLOGY (2017)
Potential drug-drug interactions among hospitalized patients in a developing country
Sarah Mousavi et al.
CASPIAN JOURNAL OF INTERNAL MEDICINE (2017)
Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital
Aline Teotonio Rodrigues et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Evaluation of potential drug-drug interactions among Palestinian hemodialysis patients
Rowa Al-Ramahi et al.
BMC NEPHROLOGY (2016)
Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients
Ghulam Murtaza et al.
SAUDI PHARMACEUTICAL JOURNAL (2016)
A comparison of five common drugudrug interaction software programs regarding accuracy and comprehensiveness
Raziyeh Kheshti et al.
JOURNAL OF RESEARCH IN PHARMACY PRACTICE (2016)
Drug-drug interaction software in clinical practice: a systematic review
Tina Roblek et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Evaluation of Potential Drug - Drug Interactions in General Medicine Ward of Teaching Hospital in Southern India
Akram Ahmad et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2015)
A study of potential drug-drug interactions among hospitalized cardiac patients in a teaching hospital in Western Nepal
Sushmita Sharma et al.
INDIAN JOURNAL OF PHARMACOLOGY (2014)
Drug-Drug Interactions Associated with Length of Stay and Cost of Hospitalization
Cristiano Moura et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2009)
Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs
Marta Sousa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Risk factors for potential drug interactions in general practice
Lars Bjerrum et al.
European Journal of General Practice (2008)
Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City
Svetlana Vladislavovna Doubova (Dubova) et al.
BMC HEALTH SERVICES RESEARCH (2007)
Potential drug interactions and duplicate prescriptions among cancer patients
Rachel P. Riechelmann et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Effect of Ranitidine on the antiplatelet effects of Aspirin in healthy human subjects
Eli I. Lev et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins
Sabin S. Egger et al.
DRUGS & AGING (2007)
Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation - A new drug-drug interaction
WC Lau et al.
CIRCULATION (2003)
Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers
J Lindenfeld et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Share Paper
